This phase II trial evaluates a mobile application (IntelliCare) in reducing distress in stage I-III breast cancer survivors. The psychological toll of cancer treatment can sometimes go unnoticed for breast cancer survivors. A suite of smartphone applications called IntelliCare may help in decreasing mood symptoms among women with breast cancer. This study may help gather information about how patients use and respond to supportive smartphone applications.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04583891.
PRIMARY OBJECTIVES:
I. To test the impact of the IntelliCare applications (apps) on symptoms of depression and anxiety in breast cancer survivors.
II. To test the impact of added coaching on engagement with the IntelliCare apps.
III. To understand breast cancer survivors’ perspectives on tailoring the apps and coaching.
OUTLINE: Patients are randomized to 1 of 2 groups.
GROUP I: Patients use an app with information about distress management including mood related distress symptoms, causes, and factors that impact distress and management strategies for 8 weeks.
GROUP II: Patients use 1-2 smartphone apps per week in IntelliCare app program to improve mood over 8 weeks. Depending on app use, patients may be randomized to 1 to 2 additional groups.
GROUP IIA: Patients classified as low-engagers continue to use the app and receive a coaching call over 40 minutes and then a brief check-in 3 weeks later.
GROUP IIB: Patients classified as high-engagers continue to use the app.
Trial PhasePhase II
Trial Typesupportive care
Lead OrganizationUniversity of Virginia Cancer Center
Principal InvestigatorPhilip I-Fon Chow
